Xtant Medical wins auction for Surgalign's biologics and spinal fixation assets

Xtant Medical Holdings, Inc.

Won auction for Surgalign's domestic and international biologics and spinal fixation assets via initial bid from June 18 APA.
Closing expected after Bankruptcy Court sale hearing on Aug 8, 2023, but no later than Sep 1, 2023.
CEO Sean Browne expects assets to contribute to growth, complementing earlier Coflex acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.